Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-762-8 | CAS number: 622-97-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- sub-chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
Materials and methods
- Principles of method if other than guideline:
- Two dose levels applied for 21 days.
- GLP compliance:
- no
Test material
- Reference substance name:
- 4-methylstyrene
- EC Number:
- 210-762-8
- EC Name:
- 4-methylstyrene
- Cas Number:
- 622-97-9
- Molecular formula:
- C9H10
- IUPAC Name:
- 1-ethenyl-4-methylbenzene
- Test material form:
- liquid
- Details on test material:
- - Name as cited in study report: MCTR-243-77
Constituent 1
- Specific details on test material used for the study:
- Lot Nr.: 145070177-2
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- New Zealand White rabbits: weight 2.05 to 2.55 Kg acclimatised for 7 days and housed individually in a laminar flow room. Diet (Purina Rabbit Chow) and water ad libitum.
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Application site of approximately 25 % of total body surface was clipped free of hair prior to study and once weekly. One rabbit per group/sex abraded at the test site with a clipper head before each application.
The test substance was delivered from a glass syringe and spread evenly over the test site and left for 6 hours before the area was rinsed with water and dried. Rabbits were maintained in a harness during the exposure period to prevent oral ingestion. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 6 hours
- Frequency of treatment:
- daily for 21 days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.5 other: mL/kg
- Remarks:
- nominal per unit body weight
- Dose / conc.:
- 0.2 other: mL/kg
- Remarks:
- nominal per unit body weight
- No. of animals per sex per dose:
- 3 males and 3 females
- Control animals:
- other: 2.0 mL/kg distilled water
- Details on study design:
- Eighteen New Zeeland rabbits (nine males and nine females) weighing from 2.05 kg to 2.55 kg were randomized by weight into three groups of three males and three females each. Animals were dosed daily, for 21 days at dose volumes of 0.5 or 2.0 mL/kg of the test substance and 2.0 mL/kg distilled water (controls).
Examinations
- Observations and examinations performed and frequency:
- Observations: daily
Skin irritation scores: twice daily, before and after application
Clinical pathology: prior to treatment and at the end of treatment. Blood collected from the ear artery.
Haematology: PCV, Haemoglobin, MCV, RBC, WBC (total and differential)
Clinical chemistry: glucose, BUN, alkaline phosphatase, SGOT, SGPT, bilirubin, total protein, calcium and phosphorus - Sacrifice and pathology:
- At the end of the 21-day period, all rabbits were weighed, anesthetized with sodium pentobarbital and exsanguinated. A necropsy to observe gross lesions was performed and the following tissues were fixed in 10% buffered formalin and evaluated histomorphologically: skin, heart, lung, adrenals, brain, gonads, liver, kidney, spleen, stomach, du odenum, bone marrow, bladder, pancreas, pituitary, unusual lesions, mesentery lumph node.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- All rabbits experienced pain when the test substance was applied.
- Dermal irritation:
- effects observed, treatment-related
- Description (incidence and severity):
- The test substance was a skin irritant at both dose levels. Observation at skin site included thickening of the epidermins, congestion, edema, inflammatory cellular infiltration, serum exudates and necrotic cellular debris on the surface.
After the first application there was very slight erythema and edema, by day 4 the severity was slight and coriaceious skin and atonia were apparent. After the 5th application moderate to marked fissuring of the skin was noted eventually leading to slight bleeding from the fissures. By day nine the surface layer of skin sloughed or peeled off and the underlying skin was golden to black colour. The severity of skin response was similar in both test groups. - Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- There was a dose related decrease in body weight, considered to be a consequence of the pain and irritation at the skin application site.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Effects on WBC due to irritation: elevated WBC and increase in segmented and non-segmented neutrophils.
- Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Elevated SGOT and considered to be related to skin cell damage.
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- No evidence of systemic pathology. The renal collecting tubules of some of the rabbits were more visible than normally observed and they were white and the renal medulla was brownish – pink (pale) olor rather than a normal red colour.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not specified
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Sex:
- male/female
- Basis for effect level:
- other: Skin irritation at both dose levels
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, there were no results to suggest systemic toxicity. However, the test substance caused moderate to severe skin irritation. Further, the irritation resulted in pain, reduced body weight, elevated WBC and increase in segmented and non-segmented neutrophils. By day nine the surface layer of skin sloughed or peeled off and the underlying skin was golden to black colour. The severity of skin response was similar in both test groups. The only effect on the clinical chemistry parameters was an elevation in the serum glutamic oxaloacetic transaminase(SGOT) ezyme which probably is related to the skin cell damage at the application site. The renal collecting tubules of some of the rabbits were more visible than normally observed and they were white and the renal medulla was brownish – pink (pale) colour rather than a normal red colour. No NOAEL was established for the study (Adamik, 1977).
- Executive summary:
A study was conducted to determine the toxicity of the test substance when applied to the skin of albino rabbits during a period of 21 consecutive days. The test substance was applied dermally to groups of 3 male and 3 female New Zealand rabbits, daily, at dose volumes of 0.5 or 2.0 mL/kg bw/day. Controls received 2.0 mL/kg bw/day of distilled water. The test substance was in contact with the skin, non-occluded, for 6 h each day. Clinical signs were recorded daily and body weight weekly. Blood samples for haematology and clinical chemistry were taken prior to treatment and at termination. All rabbits were subject to necropsy and limited histopathology. Under the study conditions, there were no results to suggest systemic toxicity. However, the test substance caused moderate to severe skin irritation. Further, the irritation resulted in pain, reduced body weight, elevated white blood cells and increase in segmented and non-segmented neutrophils. By Day 9, the surface layer of skin sloughed or peeled off and the underlying skin was golden to black colour. The severity of skin response was similar in both test groups. The only effect on the clinical chemistry parameters was an elevation in the serum glutamic oxaloacetic transaminase (SGOT) enzyme which was probably related to the skin cell damage at the application site. The renal collecting tubules of some of the rabbits were more visible than normally observed and they were white and the renal medulla was brownish – pink (pale) colour rather than a normal red colour. No NOAEL was established for the study (Adamik, 1977).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.